Sanofi India Ltd — Capital/Financing Update 2019

Sep 11, 2019

==> picture [70 x 72] intentionally omitted <==

#	Particulars	Details
1	The amount and percentageofthe	Asdisclosed above
	turnoverorrevenueorincome and net
	worth contributed by such unitordivision
	ofthe listed entity during the last financial
	year
2	Date on which the agreement for sale has	1 01hSeptember 2019
	been entered into
3	Theexpected dateofcompletion of	The transaction is expected to be completed
	sale/disposal	by 31stMarch 2020
4	Consideration received from such	Total considerationofthe transaction is Rs.
	sale/disposal	2,617 million, subject to customary working
		capital adjustments, which will be received
		after completionofcertain conditions and
		closing ofthe transaction
5	Brief detailsofbuyers and whether anyof	The buyerofthis business is Zentiva Private
	the buyers belong to the promoter/	Limited
	promoter group/group companies. If yes,
	details thereof	Thebuyer does not belong to promoter_I_
		promotergroup
6	Whether the transaction would fall within	No
	related party transactions? If yes, whether
	the same is done at arms'length
7	Additionally, in caseofa slump sale,	As disclosed above
	indicative disclosures provided for
	amalgamation/merger, shall be disclosed	There will not be any change in the
	by the listed entity with respect to such	shareholding patternofthe Company due to
	slump sale	this transaction